Last Posted: Jul 12, 2020
- Genetic Testing in Dyslipidemia A Scientific Statement from the National Lipid Association
EE Brown et al, NLA, July 9, 2020 - Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
Chan Dick C et al. Clinical chemistry 2019 65(10) 1258-1266 - Clinical outcomes of a genomic screening program for actionable genetic conditions.
Buchanan Adam H et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jun - Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.
Lacaze Paul et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jul - Can genetic testing help in the management of dyslipidaemias?
Lazarte Julieta et al. Current opinion in lipidology 2020 Jun - Health economic evaluation of screening and treating children with familial hypercholesterolemia early in life: Many happy returns on investment?
Ademi Zanfina et al. Atherosclerosis 2020 May 3041-8 - Familial Hypercholesterolemia and the Founder Effect Among Franco-Americans: A Brief History and Call to Action.
Mszar Reed et al. CJC open 2020 May 2(3) 161-167 - Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Hu Pengwei et al. Circulation 2020 Jun 141(22) 1742-1759 - Familial Hypercholesterolemia: Cardiovascular Risk Stratification and Clinical Management
J Kolominsky et al, ACC, June 1, 2020 - Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
Beheshti Sabina O et al. Journal of the American College of Cardiology 2020 May 75(20) 2553-2566
.png)
No hay comentarios:
Publicar un comentario